The previous studies from Baginska et al. demonstrated that targeting the autophagy gene BECN1 prevented the degradation of NK-derived granzyme B, and therefore restored their susceptibility to NK cell-mediated killing and significantly inhibited tumor growth in syngeneic melanoma and breast mouse models (277). The gene discussed is BECN1; the disease is neoplasm.